Recent News 45 : BREAKING NEWS, 2025 Phage Therapy Workshop – Free Event

-

 2025 Phage Therapy Workshop – Free Event

November 25th, 2025 at the Spine Building in Liverpool

Rising levels of antimicrobial resistance threaten healthcare systems and economies worldwide. Phage therapy has proven to be an effective last-resort treatment against multidrug resistant bacterial infections, but faces multiple barriers to its widespread use. Join our inter-disciplinary panel of speakers to discuss the advances, challenges, and next generation of phage therapy across the globe.

This workshop is led by our scientific committee: Stineke van Houte, Jo Fothergill, Edze Westra, and Mike Brockhurst.

Registration

Click here to register with our Eventbrite page! As places are limited, kindly inform the organizers if you will be unable to attend. For any questions, please e-mail H.E.Westlake@exeter.ac.uk

Programme

SESSION 1: Phage therapy across the globe
9.00-9.30   Jean-Paul Pirnay, Queen Astrid Military Hospital, Brussels, Belgium
9.30-10.00  Joanne Santini, University College London, UK
10.00-10.30 Stan Brouns, Delft University of Technology, The Netherlands
10.30-11.00 Graham Hatfull, University of Pittsburgh, USA
      
11.00-11.30 COFFEE
      
SESSION 2: Next generation of phage therapies
11.30-12.00 Vivek Mutalik, Lawrence Berkeley Laboratory, USA
12.00-12.30 Balint Kintses, HCEMM, BRC Szeged, Hungary
12.30-1.00  Antonia Sagona, University of Warwick, UK
      
1.00-2.00   LUNCH
      
SESSION 3: Implementation of phage therapy in the UK
2.00-2.30   Carmen Coxon, MRHA
2.30-3.00   Mark Sutton, UKHSA
3.00-3.30   Libby Duignan, Centre for Process Innovation, Liverpool
      
3.30-4.00   COFFEE

4.00-4.15   CLOSING REMARKS
      
4.00-5.00   PANEL DISCUSSION led by Dr. Fran Hodges (Innovate UK)

Followed by a reception with drinks and light snacks.

This workshop is jointly hosted by the Universities of Manchester, Liverpool and Exeter, with funding from UK Research and Innovation.

DOWNLOAD THE PROGRAM HERE

  • Environment and Sustainability Institute,
    Penryn Campus, University of Exeter,
    Penryn TR10 9FE, UK

  • Contacts:

  • Stineke van Houte, Principal Investigator: C.van-Houte@exeter.ac.uk

  • Hannah Westlake, Project Admin: H.E.Westlake@exeter.ac.uk

    • Comments

    Post a Comment

    Popular posts from this blog

    History Part 12 : Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s)

    -
    Image
    Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s) The period following World War II marked a decisive turning point in the trajectory of phage therapy in Western medicine. Despite the promising results bacteriophages had demonstrated prior to the war as potential antibacterial agents, the decades after 1945 saw a dramatic decline in interest, funding, and scientific engagement with phage therapy in the United States and much of Western Europe. This marginalization can be attributed to a confluence of scientific, sociopolitical, and economic factors that reshaped the landscape of infectious disease treatment and research. Artistic View One of the key contributors to this decline was the overwhelming optimism surrounding the newly discovered class of antibiotics. The post-war pharmaceutical revolution brought forward a series of broad-spectrum antibiotics such as streptomycin, tetracycline, and chloramphenicol, which were viewed as miracle drugs capable o...
    Read more

    The Phage Therapy in the spotlight !

    -
    Image
    Bacteriophages: Ancient Predators and the Next Frontier in Medicine In the animated documentary The Deadliest Being on Planet Earth , the Kurzgesagt team delves into the world of bacteriophages—viruses that prey exclusively on bacteria. With vibrant visuals and precise narration, the video introduces viewers to an invisible ecosystem where microscopic hunters orchestrate life-and-death dramas that shape the biosphere. These entities, though virtually unknown to the general public, may soon become central to the future of medicine. At the heart of the video lies a paradox: bacteriophages (or "phages") are among the most abundant biological entities on Earth—outnumbering all other organisms combined—yet their therapeutic potential has been largely sidelined in the antibiotic era. The video outlines the historical trajectory of phage research, spotlighting Félix d’Hérelle’s early 20th-century work and the rise of phage therapy, only to show how it was later eclipsed by the dis...
    Read more

    Paper 3 : Phage Therapy May Treat Drug Resistance in Patients With Cystic Fibrosis, Study Finds

    -
    Image
    Phage Therapy May Treat Drug Resistance in Patients With Cystic Fibrosis, Study Finds June 13, 2025 "Yale's university researchers find a new approach to combatting antimicrobial resistance. Antimicrobial resistance, in which germs like bacteria and fungi no longer respond to medicines, is a rising global threat. When antibiotics and other drugs become ineffective, infections can become difficult or impossible to treat, leading to an increase in the spread and severity of disease. In a new study, published in Nature Medicine , a team of researchers at the Center for Phage Biology and Therapy at Yale discovered a novel approach that may revolutionize the fight against antimicrobial resistance. Jon Koff, MD, with a patient Credit: Robert A. Lisak For the study, the research team investigated the use of phage therapy—the use of viruses, or phages, to target and kill bacteria—to help patients with cystic fibrosis, a disease in which antimicrobial resistance is a significant issue....
    Read more